Calithera Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(0.0%),Takeda Ventures, Inc(0.0%)
Calithera Biosciences | 4:持股变动声明-其他相关方 TAKEDA PHARMACEUTICAL CO LTD
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Mark N. Lampert(9.99%),BVF Inc.(9.99%)等
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(5.1%),Citadel Advisors Holdings LP(5.1%)等
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-PRIMECAP Management Company(8.24%)
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-PRIMECAP Management Company(4.11%)
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Incyte Corporation(0%)
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-PRIMECAP Management Company(8.35%)
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(15.00%),Takeda Ventures, Inc(15.00%)
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
Calithera Biosciences | 4:持股变动声明
暂无数据